Improved disease markers suggest dual response in a patient with metastatic castration resistant prostate cancer and chronic lymphocytic leukemia following active cellular immunotherapy

Prostate cancer and chronic lymphocytic leukemia (CLL) are relatively common malignancies associated with advanced age. Although immunotherapy-based strategies are used to treat both, currently, there is no overlap in specific therapies. Sipuleucel-T is an active cellular immunotherapy that improves...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Heather H., Soleau, Colleen, Yu, Evan Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440265/
https://www.ncbi.nlm.nih.gov/pubmed/25966929
http://dx.doi.org/10.1186/s13045-015-0149-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440265/
https://www.ncbi.nlm.nih.gov/pubmed/25966929
http://dx.doi.org/10.1186/s13045-015-0149-x

Ejemplares similares